Aromatase Inhibitors

Showing 11 to 11 of 11 articles
Clear Filters

Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors.

Acta reumatologica portuguesa
Breast cancer is the most commonly diagnosed cancer among women, but despite survival rates improvement, it is still the second major cause of cancer related death. In postmenopausal women with estrogen receptor (ER) dependent breast cancer, hormone ...